New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 7, 2014
05:54 EDTGWPHGW Pharmaceuticals reports Q2 EPS (4.1c), may not compare to consensus (48c)
Reports Q2 revenue $12.55M, consensus $12.48M.
News For GWPH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2014
11:44 EDTGWPHOptions with increasing implied volatility
Subscribe for More Information
September 29, 2014
11:40 EDTGWPHOptions with increasing implied volatility
Subscribe for More Information
September 25, 2014
10:24 EDTGWPHGW Pharmaceuticals management to meet with Leerink
Subscribe for More Information
September 22, 2014
07:51 EDTGWPHGW Pharmaceuticals could trade up 25% on data, says Leerink
Leerink believes shares of GW Pharmaceuticals could trade up 25% should the Epidiolex data in pediatric epilepsy show a seizure reduction materially greater than 44%. The data is expected in the second half of 2014. The firm says shares could trade up 15% higher on a reduction at or close to 40%, or 15% lower if the mean reduction is in the 20%-30% range. Leerink is bullish ahead of the data readout after reviewing the cannabidiol epilepsy literature and previous anti-epileptic drug trials. It has an Outperform rating on shares of GW Pharmaceuticals with a $110 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use